Hi-tech eye treatment success.
Dr Wael Wajeeh, ophthalmology surgeon at the centre and a FRCS, said the new treatment was first successfully used in a Swiss medical centre in 2001. It was then accredited by the European Union in 2009 and will be accredited by the US Food and Drug Administration this year, after positive clinical results were achieved in 11 specialist centres in the US.
Riboflavin, vitamin B2, is used in the form of eye drops, then 30 minutes later the eye is exposed to ultra-violet rays for another 30 minutes.
This strengthens the texture of the cornea and assists in retaining its natural form.
Dr Wajeeh added the new technology will limit the need for cornea implantation and is much safer to use.
Copyright 2012 Al Hilal Publishing & Marketing Group
Provided by Syndigate.info an Albawaba.com company